Russia transfers biopharmaceutical production technology to Vietnam

Under the agreement, the two parties will collaborate on research and development, production, clinical trials of new drugs and vaccines, and distribution of Medsintez’s high-quality pharmaceuticals in Vietnam and the ASEAN region.

At the signing ceremony between Medsintez and VNVC Vaccine and Biopharmaceutical Manufacturing Plant (Source: vnexpress.net)
At the signing ceremony between Medsintez and VNVC Vaccine and Biopharmaceutical Manufacturing Plant (Source: vnexpress.net)

Hanoi (VNA) - Russian pharmaceutical company Medsintez and VNVC Vaccine and Biopharmaceutical Manufacturing Plant have signed a comprehensive technology transfer agreement to produce biopharmaceuticals.

The signing ceremony took place on September 12 evening, witnessed by Russian Minister of Health Mikhail Murashko and Vietnamese Minister of Health Dao Hong Lan. This follows the Vietnam Vaccine JSC (VNVC)’s comprehensive cooperation agreement with the Russian Direct Investment Fund (RDIF) in May.

Under the agreement, the two parties will collaborate on research and development, production, clinical trials of new drugs and vaccines, and distribution of Medsintez’s high-quality pharmaceuticals in Vietnam and the ASEAN region. The transferred advanced biopharmaceutical products include recombinant albumin, recombinant insulin; single-use and reusable insulin pens; diabetes treatments such as liraglutide and semaglutide; anticoagulant heparin; antiviral Triazavirin; and follicle-stimulating hormone used in infertility treatments.

VNVC and Medsintez will also jointly conduct clinical research on the antiviral drug Triazavirin for treating dengue fever, potentially enhancing Vietnam’s capacity to combat dengue outbreaks.

Ngo Chi Dung, Chairman and CEO of the VNVC Vaccine and Biopharmaceutical Manufacturing Plant, said that by the end of 2027, the VNVC factory is expected to begin producing next-generation vaccines and advanced biopharmaceuticals developed in Russia and other countries.

Speaking at the event, Vietnamese Minister of Health Dao Hong Lan highlighted health care as a key cooperation area, reflecting the strong and trusted ties between Russia and Vietnam in medical training, drug and vaccine supply, modern technology, and healthcare infrastructure development. She expressed her hope that collaboration between research institutes and high-tech medical centres in both countries would open new opportunities, especially in cancer treatment and pharmaceutical manufacturing.

VNVC currently operates nearly 240 vaccination centres nationwide, administering tens of millions of high-quality vaccine doses annually. The recently launched VNVC vaccine factory aims to supply hundreds of millions of vaccine doses and biological products each year once operational.

Earlier in May 2025, VNVC signed agreements with leading biotechnology partners, including Gamaleya National Research Centre for Epidemiology and Microbiology and Russia’s Binnopharm Group, to promote research, investment, technology transfer, and commercialisation of biopharmaceuticals and advanced vaccines, including mRNA cancer vaccines.

Medsintez is a leading Russian biopharmaceutical company with over 20 years of experience in research, development, and production of pharmaceuticals, medical devices, and active pharmaceutical ingredients. Renowned for its robust R&D capabilities and internationally certified manufacturing, Medsintez is a trusted partner in global technology transfer programmes./.

VNA

See more

From 2026, all residents in Ho Chi Minh City will receive periodic health check-ups or screening at least once a year under a roadmap. Illustrative image. (Photo: VNA)

Ho Chi Minh City to offer annual health check-ups for residents

In the initial phase in 2026, priority will be given to children under 24 months old, students, out-of-school minors, contracted employees, probationary workers, apprentices, public officials, members of the armed forces, social protection beneficiaries and people aged 60 and above.

Patients register at the reception desk upon arrival for medical examination. (Photo: VNA)

Ho Chi Minh City targets free basic hospital fees for residents by 2030

Under the programme, the southern largest economic hub has set several key health targets to be achieved by 2030. The average height of children and adolescents under 18 is expected to increase by at least 1.5cm, while the average life expectancy of residents is projected to reach around 77 years, including at least 68 years of healthy living.

Vietnamese Ambassador to Laos Nguyen Minh Tam extends greetings to leaders and staff of the Hanoi – Vientiane General Hospital on the occasion of the 71st anniversary of the Vietnamese Doctors’ Day on February 27. (Photo: VNA)

Vietnamese doctors in Laos help foster bilateral solidarity

Commending the Hanoi – Vientiane General Hospital’s 13-year development, Ambassador Nguyen Minh Tam noted that prioritising conscience and virtue has helped it build a strong reputation among Lao citizens, the Vietnamese community and international friends in Laos.

Organ transplantation at the University Medical Centre Ho Chi Minh City (Photo: the University Medical Centre Ho Chi Minh City)

Professional excellence, dedication define Vietnam’s healthcare system

When patients pull through from the brink of death, when their vital signs stabilise and transplanted hearts begin beating strongly in new bodies, the joy shared by the entire medical team is overwhelming. And when the country welcomes the New Year, saving lives takes on an even more profound significance — offering patients and their families a new spring of hope.

At Phu Rieng communal medical station in Dong Nai province (Photo: VNA)

Vietnam fosters maternal and child healthcare, advances toward 2035 goals

The under-five mortality rate in Vietnam in 2025 was estimated at below 16 per 1,000 live births, more than three times lower than the 1990 level. The infant mortality rate (under one year) declined fourfold to below 11 per 1,000, while the neonatal mortality rate dropped fivefold, from 44 per 1,000 in 1990 to 8.8 per 1,000 in 2025.

Medicine support programmes provide significant benefits to patients throughout their course of treatment. (Photo: VNA)

Over 6,000 patients receive free medicines

The schemes focus primarily on cancer, rare diseases and severe chronic conditions, areas where treatment costs are high and often require expensive biological and originator drugs.

A lung transplant surgery at the National Lung Hospital (Photo: VNA)

Vietnam reaches new height in organ transplantation

From demanding cross-country transplants to highly specialised procedures nearing regional and international standards, the sector has created new chances of survival for thousands of patients. However, persistent bottlenecks in organ donation and the legal framework highlight the urgent need to further perfect the national donation–transplantation system. In the era of advanced medicine, progress is measured not only by surgical mastery, but also by the ability to turn loss into hope and sustain life.

The DAV asks pharmacy producers and distributors to increase medicine supply capacity during Tet to meet increasing demand (Photo: VNA)

Measures rolled out to ensure adequate medicine supply during Tet

Accordingly, provincial and municipal health departments are required to direct hospitals, centres for disease control and health care facilities to urgently develop plans and carry out medicine procurement to ensure sufficient supply, absolutely avoiding shortages. Medicines must meet quality standards and be sold at reasonable prices, with no sudden price increases allowed.

Military doctors conduct ultrasound examinations for residents in Dong Dang town, Cao Loc district, Lang Son province. (Photo: VNA)

Resolution 72 opens path to a modern, sustainable healthcare system

To build a resilient healthcare system capable of meeting the challenges of ageing, emerging diseases and rising expectations for quality care, Vietnam must continue to strengthen primary and preventive care, invest in human resources, accelerate digitalisation and big data development, and refine healthcare financing mechanisms.